Cargando…

Associations between plasma levels of C-reactive protein and catecholamine metabolites in patients with major depression

Detalles Bibliográficos
Autores principales:	Yoshimura, Reiji, Okamoto, Naomichi, Konishi, Yuki, Ikenouchi, Atsuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132088/ https://www.ncbi.nlm.nih.gov/pubmed/34035894 http://dx.doi.org/10.1177/20451253211015837

Ejemplares similares

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Comparison of psychiatric symptoms between patients with major depression with higher and lower levels of high-sensitivity C-reactive protein in the serum: a preliminary study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder
por: Ikenouchi, Atsuko, et al.
Publicado: (2021)

Major depression with musical obsession treated with vortioxetine: a case report
por: Yoshimura, Reiji, et al.
Publicado: (2021)

A Case of Major Depression with Burning Mouth Syndrome and Tinnitus Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Influence of antidepressants on plasma levels of nitric oxide metabolites in patients with major depressive disorder – RETRACTION
por: Ikenouchi, Atsuko, et al.
Publicado: (2022)

Vortioxetine Improved Depressive State In Parkinson’s Disease
por: Yoshimura, Reiji, et al.
Publicado: (2021)

Colchicine-Resistant Familial Mediterranean Fever With Depressive State Successfully Treated With Escitalopram
por: Toshida, Masamitsu, et al.
Publicado: (2021)

Effect of the personality traits of healthy Japanese workers on depressive symptoms and social adaptation, and on the achievement rate of exercise therapy to prevent major depression
por: Ikenouchi, Atsuko, et al.
Publicado: (2023)

Panic Disorder Induced by the Coronavirus Disease Pandemic in a Patient with Organic Mood Disorder Successfully Treated with Vortioxetine
por: Yoshimura, Reiji, et al.
Publicado: (2020)

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
por: Yoshimura, Reiji, et al.
Publicado: (2019)

Volume of Amygdala Subregions and Clinical Manifestations in Patients With First-Episode, Drug-Naïve Major Depression
por: Tesen, Hirofumi, et al.
Publicado: (2022)

Hippocampal Volume and Plasma Brain-Derived Neurotrophic Factor Levels in Patients With Depression and Healthy Controls
por: Fujii, Rintaro, et al.
Publicado: (2022)

Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
por: Hoshikawa, Takashi, et al.
Publicado: (2022)

A Low Clozapine Dose Improved Refractory Tardive Dystonia without Exacerbating Psychiatric Symptoms: A Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression
por: Yoshimura, Reiji, et al.
Publicado: (2023)

Efficacy of Electroconvulsive Therapy for Neuropathic Pain Comorbid with Major Depression
por: Ueda, Masashi, et al.
Publicado: (2020)

Gyrification patterns in first-episode, drug-naïve major depression: Associations with plasma levels of brain-derived neurotrophic factor and psychiatric symptoms
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Volume of Amygdala Subregions and Plasma Levels of Brain-Derived Neurotrophic Factor and Cortisol in Patients with s/s Genotype of Serotonin Transporter Gene Polymorphism of First-Episode and Drug-Naive Major Depressive Disorder: An Exploratory Study
por: Okamoto, Naomichi, et al.
Publicado: (2022)

Disturbed hippocampal intra-network in first-episode of drug-naïve major depressive disorder
por: Watanabe, Keita, et al.
Publicado: (2022)

A Young Japanese Patient with Spinocerebellar Ataxia Type 3 Presenting Depressive State with Cenesthopathy and Delusion: a Case Report
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Associations Between the Kynurenine Pathway, Proinflammatory Cytokines, and Brain-Derived Neurotrophic Factor in Hospitalized Patients With Chronic Schizophrenia: A Preliminary Study
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional Study
por: Yoshimura, Reiji, et al.
Publicado: (2018)

Serum Extracellular Vesicle-Derived hsa-miR-2277-3p and hsa-miR-6813-3p Are Potential Biomarkers for Major Depression: A Preliminary Study
por: Seki, Issei, et al.
Publicado: (2023)

Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study
por: Okamoto, Naomichi, et al.
Publicado: (2020)

Volumetric assessment of individual thalamic nuclei in patients with drug-naïve, first-episode major depressive disorder
por: Chibaatar, Enkhmurun, et al.
Publicado: (2023)

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Duloxetine, a Selective Noradrenaline Reuptake Inhibitor, Increased Plasma Levels of 3-Methoxy-4-hydroxyphenylglycol but Not Homovanillic Acid in Patients with Major Depressive Disorder
por: Atake, Kiyokazu, et al.
Publicado: (2014)

Acute pancreatitis during valproic acid administration in a patient with vascular dementia, epileptic seizures, and psychiatric symptoms: a case report
por: Yanaga, Mako, et al.
Publicado: (2023)

A Metabolomics Study of Serum in Hospitalized Patients With Chronic Schizophrenia
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Increased Stimulation Intensity Helped to Cope with Prolonged Seizures During the Next Round of Modified Electroconvulsive Therapy: A Case Report
por: Katsumura, Tetsuya, et al.
Publicado: (2022)

Prolonged delirium caused by lithium poisoning in an endometrial cancer patient at advanced stage: A case report
por: Natsuyama, Tomoya, et al.
Publicado: (2023)

Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
por: Yoshimura, Reiji, et al.
Publicado: (2017)

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder
por: Katsuki, Asuka, et al.
Publicado: (2020)

Catecholamine induced cardiomyopathy in phaeochromocytoma
por: Panda, Prashant K., et al.
Publicado: (2014)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Continuous decrease in serum brain-derived neurotrophic factor (BDNF) levels in a neuropsychiatric syndrome of systemic lupus erythematosus patient with organic brain changes
por: Ikenouchi-Sugita, Atsuko, et al.
Publicado: (2008)

Brain structural network alterations related to serum cortisol levels in drug-naïve, first-episode major depressive disorder patients: a source-based morphometric study
por: Nguyen, LeHoa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c0sfgkn7a2v05ru2a6l8ecilej